TY - JOUR
T1 - Cell-mediated immunity to tumor antigen in Marek's disease
T2 - susceptibility of effector cells to antithymocyte serum and enhancement of cytotoxic activity by Vibrio cholerae neuraminidase
AU - Sharma, J. M.
PY - 1977
Y1 - 1977
N2 - Spleen cells from chickens inoculated 7 to 8 days previously with Marek's disease virus were cytotoxic for 51Cr-labeled cells of a Marek's disease lymphoblastoid cell line (MSB-1 line) in a 4-h in vitro cytotoxic assay. The cytotoxic activity of spleen cells was inhibited by pretreatment with antithymocyte serum and complement, but not with complement alone or in combination with antibursa cell serum or normal preimmune serum. The conclusion was that the effector cell in the above cytotoxic assay was a thymus-derived lymphocyte. Also, pretreatment of target cells with Vibrio cholerae neuraminidase enhanced in vitro cytotoxic activity of effector cells. Similar enzymatic treatment of effector cells had a negligible effect on cytotoxicity.
AB - Spleen cells from chickens inoculated 7 to 8 days previously with Marek's disease virus were cytotoxic for 51Cr-labeled cells of a Marek's disease lymphoblastoid cell line (MSB-1 line) in a 4-h in vitro cytotoxic assay. The cytotoxic activity of spleen cells was inhibited by pretreatment with antithymocyte serum and complement, but not with complement alone or in combination with antibursa cell serum or normal preimmune serum. The conclusion was that the effector cell in the above cytotoxic assay was a thymus-derived lymphocyte. Also, pretreatment of target cells with Vibrio cholerae neuraminidase enhanced in vitro cytotoxic activity of effector cells. Similar enzymatic treatment of effector cells had a negligible effect on cytotoxicity.
UR - http://www.scopus.com/inward/record.url?scp=0017740179&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0017740179&partnerID=8YFLogxK
U2 - 10.1128/iai.18.1.46-51.1977
DO - 10.1128/iai.18.1.46-51.1977
M3 - Article
C2 - 302827
AN - SCOPUS:0017740179
VL - 18
SP - 46
EP - 51
JO - Infection and Immunity
JF - Infection and Immunity
SN - 0019-9567
IS - 1
ER -